Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Scientists just developed an experimental compound called CS18 that targets a key cancer protein and can apparently make resistant cancer cells sensitive to existing treatments. Fees to @bcmhouston via UsePaid